Author

M. Aleshnick

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 5 Organism:mouse· 3 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Organism:non-human primate· 1

Frequent Co-Authors

B. K. Wilder· 2 shared P. Kirtley· 2 shared T. Pierson· 2 shared A. C. Winnicki· 1 shared A. Carfi· 1 shared A. J. Birkett· 1 shared A. J. R. Cooper· 1 shared A. Kalia· 1 shared

Activity by Year

2020-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

B. K. Wilder

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Analysis of the Diverse Antigenic Landscape of the Malaria Invasion Protein RH5 Identifies a Potent Vaccine-Induced Human Public Antibody Clonotype

J. R. Barrett, D. Pipini, N. D. Wright, A. J. R. Cooper, G. Gorini, D. Quinkert, A. M. Lias, H. Davies, C. Rigby, M. Aleshnick, B. G. Williams, W. J. Bradshaw, N. G. Paterson, T. Martinson, P. Kirtley, , S. J. Draper

The paper characterizes human antibodies against PfRH5, identifies key features of potent inhibitors, and demonstrates their prophylactic potential against malaria.

Cell · Sep 1, 2024Peer-reviewedImmunology

Potent AMA1-specific human monoclonal antibody against P. vivax Pre-erythrocytic and Blood Stages

A. C. Winnicki, C. L. King, J. Bosch, A. N. Malachin, L. L. Carias, Y. Skomorovska-Prokvolit, W.-H. Tham, M. H. Dietrich, J. Popovici, W. Roobsoong, J. G. Beeson, J. Sattabongkot, L. M. Yeoh, D. H. Opi, L. B. Feufack-Donfack, , B. K. Wilder

The paper isolates a human monoclonal antibody that targets Plasmodium vivax AMA1, blocking both pre-erythrocytic and blood stage infections.

bioRxiv · Feb 7, 2024 · PreprintImmunology

An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection

B. A. Bollman, N. Nunna, K. Bahl, C. J. Hsiao, H. Bennett, S. Butler, B. Foreman, K. E. Burgomaster, M. Aleshnick, W.-P. Kong, B. E. Fisher, T. J. Ruckward, K. M. Morabito, B. S. Graham, K. A. Dowd, , A. Carfi

This study compares two ZIKV mRNA vaccines, showing that mRNA-1893 provides complete protection at a lower dose than mRNA-1325 in non-human primates.

bioRxiv · Oct 11, 2022 · PreprintImmunology

Zika virus spreads through infection of lymph node-resident macrophages

H. Hickman, G. V. Reynoso, D. N. Gordon, A. Kalia, C. C. Aguilar, C. Malo, M. Aleshnick, K. Dowd, C. Cherry, J. Shannon, S. Vrba, S. Maciejewski, K. Asano, T. Pierson

This study shows Zika virus infects lymph node macrophages, which directly release virus into the blood without requiring migratory immune cells.

bioRxiv · Sep 20, 2022Microbiology

Experimental Determination of the Force of Malaria Infection Reveals a Non-Linear Relationship to Mosquito Sporozoite Loads

M. Aleshnick, V. Ganusov, G. Nasir, G. Yenokyan, P. Sinnis

The paper determines the probability of malaria infection after mosquito bites in a rodent model and finds a non-linear relationship between sporozoite load and infection likelihood.

PLOS Pathogens · May 26, 2020Peer-reviewedMicrobiology